Daphne W. Bell
National Institutes of Health(US)National Human Genome Research Institute(US)Cancer Genetics (United States)(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Endometrial and Cervical Cancer Treatments, HER2/EGFR in Cancer Research, Cancer-related Molecular Pathways, Cancer Genomics and Diagnostics
Most-Cited Works
- → Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib(2004)11,455 cited
- → DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development(1999)6,039 cited
- → Isolation of rare circulating tumour cells in cancer patients by microchip technology(2007)3,524 cited
- → Epidermal growth factor receptor mutations in lung cancer(2007)3,115 cited
- → Detection of Mutations in EGFR in Circulating Lung-Cancer Cells(2008)1,612 cited
- → Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways(2004)1,610 cited